Liver biopsy specimens from patients with MASLD show significantly reduced expression of lysosomal cathepsins (e.g., CTSB, CTSD, and CTSL) and increased p62 accumulation, indicative of autolysosomal dysfunction [75]. The gene discussed is CTSD; the disease is metabolic dysfunction-associated steatotic liver disease.